#FutureReadyHealthcare

Who We Are
Investor Relations
News
Careers
Indegene

XyloCor chooses Indegene's MME to assess PRMA landscape for refractory angina

Back to Videos

Related Insights

4:05

Cosette Pharmaceuticals chooses Indegene’s MME to assess market for 8 new cardiovascular therapies

1:01:37

Webinar: The Metaverse - What it means for life sciences companies